Emcure Pharmaceuticals

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue2,0381,9592,1212,1042,273
Expenses1,7641,7291,8501,8101,932
EBITDA416.53358.51406.86420.47478.60
EBIT319.63261.70299.64317.52373.96
Profit Before Tax273.41229.92260.62290.76341.42
Net Profit201.55156.09197.24214.79251.37
Financial Ratios
Operating Profit Margin20.81%18.27%18.74%19.85%21.09%
Net Profit Margin9.72%7.83%9.25%9.97%10.73%
Earning Per Share (Diluted)10.238.129.9710.9212.85
Dividends Per Share0.000.003.000.000.00